These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE). Olechowski CJ, Tenorio G, Sauve Y, Kerr BJ. Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347 [Abstract] [Full Text] [Related]
3. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Berard JL, Wolak K, Fournier S, David S. Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195 [Abstract] [Full Text] [Related]
4. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods. Khan N, Woodruff TM, Smith MT. Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977 [Abstract] [Full Text] [Related]
5. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z. J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385 [Abstract] [Full Text] [Related]
6. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis. Zagon IS, Rahn KA, Bonneau RH, Turel AP, McLaughlin PJ. Brain Res; 2010 Jan 15; 1310():154-61. PubMed ID: 19931226 [Abstract] [Full Text] [Related]
7. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Roscoe WA, Welsh ME, Carter DE, Karlik SJ. J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483 [Abstract] [Full Text] [Related]
8. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes. Dutra RC, Bento AF, Leite DF, Manjavachi MN, Marcon R, Bicca MA, Pesquero JB, Calixto JB. Neurobiol Dis; 2013 Jun 30; 54():82-93. PubMed ID: 23454198 [Abstract] [Full Text] [Related]
9. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Musgrave T, Benson C, Wong G, Browne I, Tenorio G, Rauw G, Baker GB, Kerr BJ. Brain Behav Immun; 2011 Nov 30; 25(8):1677-88. PubMed ID: 21723939 [Abstract] [Full Text] [Related]
11. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. Brown DA, Sawchenko PE. J Comp Neurol; 2007 May 10; 502(2):236-60. PubMed ID: 17348011 [Abstract] [Full Text] [Related]
12. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, Calabresi PA. J Neuroimmunol; 2008 Aug 13; 199(1-2):83-93. PubMed ID: 18582952 [Abstract] [Full Text] [Related]
13. Mechanical allodynia and spinal up-regulation of P2X4 receptor in experimental autoimmune neuritis rats. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. Neuroscience; 2008 Mar 18; 152(2):495-501. PubMed ID: 18276080 [Abstract] [Full Text] [Related]
14. Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent. Recks MS, Addicks K, Kuerten S. Neurosci Lett; 2011 May 02; 494(3):227-31. PubMed ID: 21406210 [Abstract] [Full Text] [Related]
15. Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis. Pifarre P, Prado J, Baltrons MA, Giralt M, Gabarro P, Feinstein DL, Hidalgo J, Garcia A. Acta Neuropathol; 2011 Apr 02; 121(4):499-508. PubMed ID: 21234581 [Abstract] [Full Text] [Related]
16. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R. J Autoimmun; 2011 Nov 02; 37(3):228-41. PubMed ID: 21752599 [Abstract] [Full Text] [Related]
17. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F. Autoimmunity; 2008 Aug 02; 41(5):405-13. PubMed ID: 18568646 [Abstract] [Full Text] [Related]
18. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis. Ford ML, Evavold BD. Eur J Immunol; 2004 Feb 02; 34(2):388-97. PubMed ID: 14768043 [Abstract] [Full Text] [Related]
19. Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis. Potter LE, Paylor JW, Suh JS, Tenorio G, Caliaperumal J, Colbourne F, Baker G, Winship I, Kerr BJ. J Neuroinflammation; 2016 Jun 10; 13(1):142. PubMed ID: 27282914 [Abstract] [Full Text] [Related]
20. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L. J Immunol; 1999 Sep 01; 163(5):2403-9. PubMed ID: 10452974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]